Superior Planning, LLC’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Superior Planning, LLC’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21.8K	Buy	+292	New	+$21.5K	0.01%	663

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Superior Planning, LLC's KNSA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 292 shares worth $21.8K. The stake represents 0.01% of the portfolio and ranks #663 among its holdings.

189 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

Superior Planning, LLC held 292 shares of Kiniksa Pharmaceuticals worth $21.8K as of Q3 2026.
Kiniksa Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Kiniksa Pharmaceuticals made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #663 holding.
189 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.